Vol. 275, Issue 5, H1567-H1576, November 1998
Mitochondrial ATP-sensitive
K+ channels modulate cardiac
mitochondrial function
Ekshon L.
Holmuhamedov,
Sofija
Jovanovi
,
Petras P.
Dzeja,
Aleksandar
Jovanovi
, and
Andre
Terzic
Division of Cardiovascular Diseases, Department of Medicine and
Pharmacology, Mayo Clinic, Mayo Foundation, Rochester, Minnesota
55905
 |
ABSTRACT |
Discovered in
the cardiac sarcolemma, ATP-sensitive
K+
(KATP) channels have more
recently also been identified within the inner mitochondrial membrane.
Yet the consequences of mitochondrial KATP channel activation on
mitochondrial function remain partially documented. Therefore, we
isolated mitochondria from rat hearts and used
K+ channel openers to examine the
effect of mitochondrial KATP
channel opening on mitochondrial membrane potential, respiration, ATP generation, Ca2+ transport, and
matrix volume. From a mitochondrial membrane potential of
180 ± 15 mV, K+ channel openers,
pinacidil (100 µM), cromakalim (25 µM), and levcromakalim (20 µM), induced membrane depolarization by 10 ± 7, 25 ± 9, and
24 ± 10 mV, respectively. This effect was abolished by removal of
extramitochondrial K+ or
application of a KATP channel
blocker. K+ channel opener-induced
membrane depolarization was associated with an increase in the rate of
mitochondrial respiration and a decrease in the rate of mitochondrial
ATP synthesis. Furthermore, treatment with a
K+ channel opener released
Ca2+ from mitochondria preloaded
with Ca2+, an effect also
dependent on extramitochondrial K+
concentration and sensitive to
KATP channel blockade. In
addition, K+ channel openers,
cromakalim and pinacidil, increased matrix volume and released
mitochondrial proteins, cytochrome c
and adenylate kinase. Thus, in isolated cardiac mitochondria,
KATP channel openers depolarized
the membrane, accelerated respiration, slowed ATP production, released
accumulated Ca2+, produced
swelling, and stimulated efflux of intermembrane proteins. These
observations provide direct evidence for a role of mitochondrial KATP channels in regulating
functions vital for the cardiac mitochondria.
heart; mitochondria; potassium channel openers; calcium
 |
INTRODUCTION |
THE POTASSIUM ION is the major cytoplasmic and
mitochondrial cation, and net flux of
K+ across the inner mitochondrial
membrane critically regulates mitochondrial activity (16). This
includes regulation of energy production and maintenance of cellular
Ca2+ homeostasis, two
mitochondrial functions essential for cellular survival (12, 15, 23,
24). To allow for bidirectional K+
cycling across an otherwise
K+-impermeable inner membrane,
mitochondria express specialized K+ conduits (16). These include
the well-characterized electroneutral K+/H+
antiporter responsible for K+
efflux, along with less known pathways for
K+ influx (8, 15).
A candidate mechanism for K+ entry
is an ATP-sensitive K+
(KATP) channel (15, 16). This
channel, known as the mitochondrial KATP channel, has been recently
identified within the inner mitochondrial membrane (29), and the
molecular identity of channel subunits has been partially characterized
(16, 59, 60). Purified channel proteins, when incorporated into
artificial bilayers or liposomes, reconstitute an ATP-sensitive
K+ conductance with properties
similar to those previously described for other members of the
KATP channel family (52). This
channel family regroups nucleotide-gated inwardly rectifying
K+ channels, which sense the
metabolic state of a cell and regulate K+ flux and membrane excitability
(1, 2, 31, 42, 46, 59, 67).
KATP channels have been originally
described in the cardiac sarcolemma (50), and opening of sarcolemmal
KATP channels has been associated
with shortening of cardiac action potential, decrease in intracellular
Ca2+ loading, and cardioprotection
during ischemia (5, 14, 20, 21, 32, 33, 44).
However, the consequences of activation of mitochondrial
KATP channels on mitochondrial
functions, including oxidative phosphorylation and
Ca2+ transport, have not been determined.
K+ channel-opening drugs are the
established tool used to activate
KATP channels (21, 54, 66) and
also target the mitochondrial KATP
channels (17, 18, 61, 62). Therefore, in this study we used
K+ channel openers to examine the
effect of mitochondrial KATP
channel opening on mitochondrial functions, including membrane
potential, respiration, ATP generation,
Ca2+ transport, and membrane
integrity. We present evidence that activation of mitochondrial
KATP channels modulates the
function of isolated cardiac mitochondria.
 |
MATERIALS AND METHODS |
Isolated cardiac mitochondria.
Cardiac mitochondria were isolated from ether- or
pentobarbital-anesthetized rats by differential centrifugation (25,
43). After thoracotomy, hearts were rapidly excised into an ice-cold isolation buffer (50 mM sucrose, 200 mM mannitol, 5 mM
KH2PO4, 1 mM EGTA, 5 mM MOPS, and 0.1% BSA, pH 7.15 adjusted with KOH), atria
were removed, and 1-mm3 pieces of
ventricular myocardium were homogenized (30 ml of isolation buffer per
heart) using a PT10/35 Polytron (Brinkman). Three 20-s homogenization
cycles were performed on ice, and then the samples were centrifuged for
10 min (at 750 g) using a Sorvall II
centrifuge equipped with a GSA rotor. The supernatant, containing the
mitochondrial fraction, was further centrifuged at 7,000 g for 20 min, and the pellet was
resuspended in 30 ml of isolation buffer (with no EGTA) and spun at
7,000 g for 20 min. Finally,
mitochondria were resuspended in the isolation buffer (with no EGTA),
and protein concentration was determined using a protein kit (Bio-Rad).
Mitochondrial suspension (~30-40 mg protein/ml) was kept on ice
before experiments.
Mitochondrial membrane potential.
Measurements were made at 30°C under continuous stirring of the
mitochondrial suspension (1 mg protein/ml incubation medium) placed
into a multichannel chamber of an ESON-6ch computerized analyzer
(25-28). The standard incubation medium contained (in mM) 110 KCl,
5 K2HPO4,
5 succinate, 5 pyruvate, and 10 MOPS (pH 7.15). Mitochondrial membrane
potential was measured with tetraphenylphosphonium (TPP+)-sensitive minielectrodes
manufactured and calibrated as described elsewhere (38).
TPP+ (200 nM) was added to the
incubation medium in the chamber before addition of mitochondria, and
mitochondrial membrane potential was calculated according to the
following equation: 
= 59 × log (v/V)
59 × log
[10(E
E0)/59
1], where 
is mitochondrial membrane potential
(mV), v is mitochondrial matrix volume (1.6 µl/mg mitochondrial
protein) (53), V is volume of incubation medium (1 ml), and
E0 and
E are electrode potentials before and
after addition of mitochondria, respectively (49). Membrane potential
was measured in the presence of K+
channel openers [pinacidil (RBI), cromakalim (Sigma Chemical), and levcromakalim (a gift from SmithKline Beecham)],
K+ ionophore (valinomycin),
and/or K+ channel blockers
[glyburide and 5-hydroxydecanoic acid (5-HD), both from
RBI]. In addition, mitochondrial membrane potential was also
measured after addition of ADP, in the absence and presence of a
K+ channel opener.
Mitochondrial respiration.
O2 consumption of mitochondria was
measured in the multichannel chamber using a calibrated Clark-type
O2 minielectrode (11, 25). For
calibration purposes, depletion of
O2 content within the
mitochondrial suspension was achieved by sodium hydrosulfite. Data
acquisition and processing were the same as with the
TPP+ electrode. The effects of
drugs were assessed on "state 2" mitochondrial respiration (7).
In addition, in certain experiments, ADP-stimulated mitochondrial
respiration ("state 3") was measured in the absence and presence
of a K+ channel opener.
Mitochondrial
Ca2+ uptake.
Mitochondrial Ca2+ uptake was
measured as a change in the free
Ca2+ concentration within the
suspension using calibrated
Ca2+-selective minielectrodes
(Microelectrodes) (11, 26, 28). Data acquisition and processing were
the same as with the TPP+
electrode. The effect of K+
channel openers on mitochondrial
Ca2+ retention and release was
studied in mitochondria preloaded with Ca2+ (3 consecutive 40-nmol
Ca2+ pulses/mg mitochondrial protein).
Mitochondrial ATP synthesis.
Mitochondrial ATP content was determined in mitochondrial extracts (9).
Briefly, 200 µl of mitochondrial suspension were treated with 20 µl
of 3.3 M HClO4, and precipitated
proteins were removed by centrifugation (60 s, 14,000 rpm, 4°C).
After neutralization of the supernatant with 80 µl of a mixture
containing 2.5 M
K2CO3 in 1 M HEPES, the precipitate was separated by centrifugation (60 s,
14,000 rpm, 4°C), and the concentration of ATP within the extract
was determined by coupled enzymatic analysis based on spectrophotometric detection of NADH (40) in the absence and presence
of a K+ channel opener.
Mitochondrial volume and integrity.
Light scattering of mitochondrial suspensions, a measure of matrix
volume (18, 24, 25), was determined within a 10-mm cuvette (maintained
at 22°C) in the presence of K+
channel openers or a K+ ionophore.
The absorbance of the mitochondrial suspension was measured at 540 nm
using a spectrophotometer (model DU-7400, Beckman).
The integrity of the mitochondrial membrane, in the absence and
presence of K+ channel openers,
was assessed by measuring release of cytochrome c and adenylate kinase, two
intermembrane proteins (47, 56). Supernatants, obtained after
sedimentation (at 14,000 g, 15 min, 4°C) of the mitochondrial suspension, were concentrated by
ultrafiltration (Centricon 3, Amicon), and an aliquot (30 µl) was
immobilized on nitrocellulose membranes (Optitran BA-NC) using a
Minifold I dot-blot system. Membrane dot blots were probed with a mouse anti-cytochrome c monoclonal antibody
(clone 6H2.B4, Pharmingen) and detected with a rabbit anti-mouse IgG
conjugated with horseradish peroxidase (Amersham), which served as a
secondary antibody. The blot was placed on the SuperSignal CL-HRP
substrate (Pierce) and exposed to an X-Omat film (Eastman Kodak) for 60 s. Adenylate kinase activity was determined within the supernatant
spectrophotometrically (9, 10, 40).
 |
RESULTS |
Effect on mitochondrial membrane potential.
Isolated cardiac mitochondria had a membrane potential of
180 ± 15 mV (n = 12), as demonstrated
using a potential-sensitive probe,
TPP+ (Fig.
1A).
Mitochondria maintained a steady membrane potential throughout the
duration of recordings (up to 40 min). Addition of the
K+ channel opener pinacidil (100 µM) induced rapid depolarization (Fig.
1A). On average, mitochondrial
membrane potential decreased by 10 ± 7 mV
(n = 5) in the presence of
100 µM pinacidil. The effect of pinacidil was concentration dependent
(Fig. 1B). The K+ ionophore valinomycin (12.5 ng/mg mitochondrial protein) also reduced mitochondrial membrane
potential, indicating that depolarization can be triggered by promoting
K+ flux across the mitochondrial
membrane (Fig. 1A).

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of pinacidil (PIN) on mitochondrial membrane potential.
Mitochondrial membrane potential was measured using the membrane
potential-sensitive probe tetraphenylphosphonium
(TPP+). Arrowhead, addition of
isolated cardiac mitochondria to a solution containing
TPP+. On addition of mitochondrial
suspension, resting membrane potential was rapidly achieved.
A: pinacidil (100 µM)-induced
membrane depolarization. K+
ionophore valinomycin (Valino, 12.5 ng/mg mitochondrial protein) was
added as a positive control. B:
concentration-response curve for effect of pinacidil on mitochondrial
membrane potential. Values are means ± SE of 3-5
measurements.
|
|
Cromakalim (Fig.
2A) and
levcromakalim (Fig.
3A),
K+ channel openers that are
structurally unrelated to pinacidil, also induced mitochondrial
membrane depolarization when applied at concentrations known to
activate plasmalemmal KATP
channels (21, 65). On average, cromakalim (25 µM) and levcromakalim
(20 µM) decreased the mitochondrial membrane potential by 25 ± 9 and 24 ± 10 mV, respectively (n = 4).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Cromakalim (CROM)-induced mitochondrial membrane depolarization and
extramitochondrial concentration of
K+.
A: cromakalim (20 µM)-induced
membrane depolarization. Valinomycin (12.5 ng/mg mitochondrial protein)
was added as a positive control. B: in
nominally K+-free solution (i.e.,
KCl replaced with 110 mM choline chloride,
K2HPO4
with 5 mM
Na2HPO4,
and pH adjusted with Trizma base), cromakalim (20 µM) was without
effect. Addition of KCl (in 4 mM steps) restored the depolarizing
effect of cromakalim. C: in
deenergized mitochondria treated with antimycin A (AntiA, 1 µg/mg
mitochondrial protein) and oligomycin (Oligo, 1 µg/mg mitochondrial
protein), cromakalim (in 25 µM steps) induced mitochondrial membrane
hyperpolarization in nominally
K+-free solution. Arrowheads,
addition of isolated cardiac mitochondria to a solution containing
TPP+. Mitochondrial membrane
potential was measured as described in Fig. 1 legend.
|
|

View larger version (7K):
[in this window]
[in a new window]
|
Fig. 3.
Levcromakalim (LEV)-induced mitochondrial membrane depolarization and a
blocker of ATP-sensitive K+
(KATP) channels.
A: levcromakalim (25 µM)-induced
membrane depolarization. Valinomycin (12.5 ng/mg mitochondrial protein)
was added as a positive control. B: in
mitochondria treated with KATP
channel blocker 5-hydroxydecanoic acid (5-HD, 20 µM), levcromakalim
(20 µM) did not induce membrane depolarization. Arrowheads, addition
of isolated cardiac mitochondria to a solution containing
TPP+. Mitochondrial membrane
potential was measured as described in Fig. 1 legend.
|
|
In nominally K+-free medium,
cromakalim could no longer induce mitochondrial depolarization (Fig.
2B). Introduction of KCl into the
medium bathing mitochondria restored the depolarizing effect of
cromakalim (Fig. 2B). Conversely, in
mitochondria in which the potential was dissipated by antimycin A (an
inhibitor of the mitochondrial respiratory chain) and oligomycin (an
inhibitor of mitochondrial ATPase), cromakalim, in the absence of
extramitochondrial K+, induced
hyperpolarization of the mitochondrial membrane (Fig. 2C). This suggests that the effect
of the K+ channel opener on
mitochondrial membrane potential is dependent on the electrochemical
gradient for K+.
The depolarizing effect of K+
channel openers was sensitive to 5-HD, a selective antagonist of
KATP channels (51). By itself, 5-HD (20 µM) had no effect on the steady-state mitochondrial membrane potential but prevented mitochondrial depolarization by levcromakalim (20 µM; Fig. 3; n = 7).
ADP, a mitochondrial substrate used in the production of ATP, is known
to induce transient mitochondrial depolarization, the duration of which
depends on the time required for conversion of ADP to ATP (43). In the
absence of a K+ channel opener,
ADP (500 µM) induced depolarization of cardiac mitochondria that
lasted 105 ± 15 s (Fig.
4A;
n = 6). In the presence of pinacidil
(100 µM-1 mM), the ADP-induced mitochondrial membrane depolarization was significantly prolonged (Fig. 4).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of pinacidil on ADP-induced mitochondrial membrane
depolarization. A: ADP (500 µM)-induced mitochondrial membrane depolarization in absence
(Control) and presence of pinacidil (100 µM).
B: concentration-response curve for
effect of pinacidil on duration of ADP (500 µM)-induced membrane
depolarization. Values are means ± SE.
|
|
Effect on mitochondrial respiration.
The rate of state 2 respiration of isolated cardiac
mitochondria was 14.0 ± 1.3 nmol
O2 · min
1 · mg
protein
1
(n = 20). Pinacidil (100 µM-1
mM), in a concentration-dependent manner, induced an increase in the
rate of mitochondrial respiration (Fig.
5A).
Pretreatment (3-5 min) of mitochondria with the
KATP channel blocker glyburide (1 µM) inhibited the effect of pinacidil on mitochondrial respiration
(Fig. 5B;
n = 3).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of pinacidil on mitochondrial
O2 consumption.
A: concentration-response curve for
effect of pinacidil on O2
consumption. Values are means ± SE.
B: glyburide (1 µM) inhibits 100 µM pinacidil-induced increase in mitochondrial
O2 consumption. Values are means ± SE. * Significant difference
(P < 0.01, Student's
t-test) between absence and presence
of glyburide.
|
|
ADP (500 µM) induced transition of mitochondria from state 2 to state
3 respiration (Fig. 6;
n = 6). Pinacidil (100 µM) slowed ADP-induced state 3 respiration (from 165 ± 7 to 55 ± 5 natoms O2 · min
1 · mg
protein
1 in the absence and
presence of pinacidil, respectively) without changing the total amount
of the ADP-stimulated O2
consumption, which was 340 ± 10 and 353 ± 8 natoms in the
absence and presence of the K+
channel opener (n = 3; Fig. 6).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of pinacidil on ADP-induced acceleration of mitochondrial
respiration. Mitochondrial rate of respiration was measured using an
O2-sensing electrode in
pinacidil-untreated (A) and
pinacidil (100 µM)-treated (B)
mitochondria under control conditions
(V2 vs.
V'2) and in presence of ADP
(V3 and
V4 vs.
V'3 and
V'4).
t, Time mitochondria spent in
ADP-induced state 3 respiration;
O2, magnitude of ADP-induced
O2 consumption. Mitochondrial
uncoupler dinitrophenol (DNP, 40 µM) was added at end of each
experiment to verify mitochondrial responsiveness. Arrowheads, addition
of isolated cardiac mitochondria.
|
|
Effect on mitochondrial ATP synthesis.
Isolated cardiac mitochondria efficiently phosphorylated ADP (500 µM)
so that ~90% of added ADP was converted to ATP within 100 ± 15 s
(n = 3; Fig.
7). The initial rate of ATP synthesis was
401 ± 35 nmol
ATP · min
1 · mg
protein
1, and the half-time
required for complete conversion of added ADP to ATP was 27 ± 5 s
(n = 3; Fig. 7). Pinacidil (100 µM)
decreased the rate of initial ATP synthesis to 187 ± 23 nmol
ATP · min
1 · mg
protein
1 and increased the
half-time required for conversion of ADP to ATP to 87 ± 7 s
(n = 3; Fig. 7). Although the rate of
mitochondrial synthesis was slowed, pinacidil (100 µM) did not
prevent conversion of ADP to ATP (Fig. 7).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of pinacidil on mitochondrial conversion of ADP to ATP. Time
course of ATP synthesis after addition of 500 µM ADP was measured in
absence and presence of 100 µM pinacidil. Values are means ± SE.
[ATP], ATP concentration.
|
|
Effect on mitochondrial
Ca2+ loading.
Mitochondria are known to accumulate and to retain
Ca2+ within the matrix (22).
Isolated cardiac mitochondria efficiently took up and retained added
Ca2+ when repeatedly challenged
with extramitochondrial Ca2+
pulses (in total 120 nmol Ca2+/mg
mitochondrial protein; Fig. 8). Addition of
pinacidil (250 µM) induced rapid release of
Ca2+ from preloaded mitochondria
(Fig. 8, A-C). The efficacy of
pinacidil to induce release of mitochondrial
Ca2+ was dependent on the
extramitochondrial concentration of
K+ (Fig. 8,
A-C). At 1, 10, and 110 mM
extramitochondrial KCl, the magnitude of pinacidil-induced
Ca2+ release was 1, 3, and 5 nmol
Ca2+/mg mitochondrial protein,
respectively (Fig. 8, A-C). The
Ca2+-releasing effect of pinacidil
(250 µM) was suppressed by pretreatment of mitochondria with the
KATP channel blocker glyburide (1 µM; Fig. 8D).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of pinacidil on Ca2+
release from mitochondria. Original records of extramitochondrial
Ca2+ concentration measured using
a Ca2+-sensitive electrode are
shown. Arrowheads, addition of mitochondrial suspension.
Ca2+ was added as a series of 3 pulses (40 nmol each) to load mitochondria.
A-C: pinacidil (100 µM)-induced
release of Ca2+ from mitochondria.
Magnitude of pinacidil-induced
Ca2+ release was dependent on
concentration of extramitochondrial
K+ (i.e., 1, 10, and 110 mM).
Treatment with glyburide (GLYB, 1 µM) suppressed pinacidil (100 µM)
to induce release of mitochondrial
Ca2+. In
D, valinomycin (12.5 ng/mg
mitochondrial protein) was added as a positive control.
|
|
Effect on mitochondrial matrix volume and integrity.
The volume of mitochondria depends on the permeability of the inner
membrane to osmotically active particles, such as
K+ (6). The
K+ channel opener cromakalim (100 µM) induced swelling of mitochondria, as revealed by a decrease in
the absorbance of the mitochondrial suspension in
K+-containing media by 0.1 ± 0.02 optical density unit (n = 3; Fig. 9A).
Under this condition, the K+
ionophore valinomycin also induced significant mitochondrial swelling
(not shown). In contrast, in
K+-free medium, cromakalim had no
significant effect on mitochondrial swelling (Fig. 9;
n = 3).
K+-dependent changes in
mitochondrial volume were also observed with pinacidil (250 µM; Fig.
9B).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 9.
Effect of K+ channel openers on
mitochondrial matrix volume. A:
original records of mitochondrial volume expressed as optical density
(OD) of mitochondrial suspension in
K+-free (sucrose: KCl was
isotonically replaced with 220 mM sucrose and
K2HPO4
with 5 mM
Na2HPO4,
and pH was adjusted with Trizma base) or
K+-containing standard incubation
medium (KCl). Arrows, addition of cromakalim (25 µM).
B: average effect of
K+ channel openers, 25 µM
cromakalim and 100 µM pinacidil, on mitochondrial volume. Values are
means ± SE. * Significantly different
(P < 0.01, Student's
t-test) from sucrose.
|
|
Cytochrome c and adenylate kinase are
located within the intermembrane space of mitochondria (58). Under
control conditions, isolated cardiac mitochondria show no
significant release of cytochrome c
(Fig. 10) or adenylate kinase (Fig.
11).
KATP channel openers pinacidil
(250 µM) and cromakalim (100 µM) induced release of cytochrome
c (Fig. 10) and adenylate kinase (Fig.
11). The K+ ionophore valinomycin
(12.5 ng/mg mitochondrial protein), used as a positive control, also
induced release of cytochrome c (Fig. 10) and adenylate kinase (Fig. 11).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 10.
Effect of K+ channel openers on
cytochrome c release from
mitochondria. Dot blots of extramitochondrial medium were obtained
using a monoclonal anti-cytochrome c
antibody (Ab) under control conditions and after treatment of
mitochondria with K+ channel
openers, pinacidil (250 µM) and cromakalim (100 µM). Valinomycin
(56 ng/mg mitochondrial protein) was used as a positive control.
|
|

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 11.
Effect of K+ channel openers on
adenylate kinase release from mitochondria. Adenylate kinase activity
was measured under control conditions and after treatment of
mitochondria with K+ channel
openers, pinacidil (250 µM) and cromakalim (100 µM). Valinomycin
(56 ng/mg of mitochondrial protein) was used as a positive control.
|
|
 |
DISCUSSION |
In the present study we report that, in mitochondria isolated from
cardiac muscle, K+ channel openers
induced membrane depolarization, accelerated respiration, slowed ATP
production, triggered release of
Ca2+, and produced swelling
associated with efflux of intermembrane proteins. In accord with an
activation of mitochondrial KATP
channels, these effects were dependent on the extramitochondrial
concentration of K+, were
inhibited by blockers of KATP
channels, and could be induced by structurally distinct
K+ channel openers. These
observations provide direct evidence for a role of mitochondrial
KATP channels in the regulation of
mitochondrial functions.
That KATP channels are present
within the inner membrane of mitochondria was initially demonstrated on
the basis of electrophysiological measurements of a
K+-selective, ATP-gated ion
conductance in fused giant mitoplasts (29). The presence of functional
KATP channels in mitochondria was
confirmed after isolation of an inner membrane protein fraction from
rat liver and beef heart mitochondria, which, when reconstituted in
liposomes or planar lipid bilayers, catalyzed electrophoretic ATP-sensitive K+ flux (52). This
ATP-inhibited K+ flux was
activated by K+ channel openers
such as cromakalim (18) and suppressed by
K+ channel blockers such as
glyburide and 5-HD (3, 17, 51, 63).
K+ influx through this channel was
hypothesized to serve as a mechanism for osmotic regulation of
mitochondrial volume (15, 23, 29, 62). In mitochondria from noncardiac
tissue, such as liver and pancreatic
-cells, openers of
KATP channels were found to affect mitochondrial energy metabolism (16, 19, 63). Thus the present findings
that opening of mitochondrial KATP
channels can modulate multiple functions in isolated cardiac
mitochondria provide direct evidence for a
KATP channel-mediated regulation
of cardiac mitochondrial behavior.
Pinacidil, cromakalim, and levcromakalim share the property to activate
KATP channels (21, 54, 66) and
were found here to depolarize the membrane potential of cardiac
mitochondria. However, it has remained controversial whether opening of
mitochondrial KATP channels can be
associated with changes in mitochondrial membrane potential (19, 61).
In pancreatic
-cells, glyburide, a
KATP channel blocker, failed to
antagonize the depolarizing effect of diazoxide, a drug with multiple
sites of action, including K+
channel activation, suggesting that diazoxide-induced membrane depolarization is not associated with activation of
KATP channels, at least in this
cell type (19). Moreover, in isolated liver mitochondria, other
K+ channel openers, including
aprikalim and nicorandil, were without effect on membrane potential,
although in the same preparation, RP-66471, a more recently developed
KATP channel opener, induced mitochondrial depolarization (61).
Here, in cardiac mitochondria, a
KATP channel-mediated regulation
of mitochondrial membrane potential is supported by three lines of
evidence. First, structurally distinct
K+ channel openers were effective
in depolarizing mitochondria. Second, the effect of
K+ channel openers on
mitochondrial membrane potential was dependent on the electrochemical
gradient for K+. Third, 5-HD, a
selective KATP channel blocker
(51), did not affect membrane potential by itself but prevented the
depolarizing action of a K+
channel opener. Our findings are in accord with the property of
cromakalim and other K+ channel
openers to induce K+ flux through
mitochondrial KATP channels (18).
Under the present experimental condition (110 mM extramitochondrial
K+ and 
=
180 mV),
opening of KATP channels is
expected to lead to K+ influx and
depolarization of mitochondria. In turn, a decrease in membrane
potential would dissipate the driving force for ATP synthesis,
triggering a compensatory activation of the mitochondrial respiratory
chain. It has previously been shown that increase in the
K+ permeability by valinomycin of
the inner membrane decreases the rate of ATP synthesis and promotes
respiration (53). The present study extends this concept and shows that
activation of KATP channels not
only induces membrane depolarization but can also reduce the rate of
ATP synthesis and increase O2
consumption in cardiac mitochondria.
In addition to energy production, mitochondria have the capacity to
store Ca2+, a function critical in
the maintenance of cellular Ca2+
homeostasis (13). In the present study, isolated cardiac mitochondria, when challenged with repeated Ca2+
pulses, displayed the property to accumulate and store
Ca2+. Opening of mitochondrial
KATP channels rapidly released
Ca2+ from preloaded mitochondria,
an effect also seen with K+
ionophores. Although the precise mechanism for such an effect on
Ca2+ release is unknown, the
sensitivity toward KATP channel
blockade and the dependence on extramitochondrial
K+ concentration are in line with
a KATP channel-mediated membrane depolarization and promotion of
Ca2+ release. Such interpretation
also concurs with the notion that setting the mitochondrial membrane
potential is critical for cyclic accumulation and release of
Ca2+ (30).
In the present study we further demonstrated that opening of
mitochondrial KATP channels
increased matrix volume, which is manifested through mitochondrial
swelling. This finding supports previous reports that mitochondrial
KATP channels can regulate the
osmotic status of the mitochondrial matrix (15, 16). Depending on the
extent of swelling, an increase in matrix volume may also lead to a
change in the permeability of the outer membrane to macromolecules that
are located within the intermembrane (47, 58). In this regard, the
present observation, that opening of K+ channels could induce release
of intermembrane proteins, is suggestive of a significant increase in
matrix volume and of a possible compromise in the integrity of the
mitochondrial membrane.
In summary, the present study provides direct evidence that opening of
mitochondrial KATP channels
modulates essential functions of isolated cardiac mitochondria. The
cellular consequences of mitochondrial
KATP channel opening are not
known. It has been proposed that this ion conductance may participate
in the protection of cardiac muscle from ischemia-reperfusion
injury (17). Because mitochondrial
Ca2+ overload is implicated in
cellular injury (13), our findings may suggest a possible beneficial
effect of mitochondrial KATP channel opening through regulation of mitochondrial
Ca2+ levels. The present study
also identifies a KATP
channel-mediated decrease in the rate of ATP synthesis and a release of
mitochondrial proteins. Because a decrease in cellular ATP content
coupled with the presence of cytochrome
c within the cytosol has been
associated with cellular apoptosis (48, 56), this further suggests that opening of mitochondrial KATP
channels may participate in the regulation of cellular viability. The
net effect of opening of mitochondrial
KATP channels is, however,
difficult to predict in view of the diversity in cellular protective
mechanisms (20, 21, 34, 35, 44, 57) and the complex nature of
KATP channel gating (2, 4, 16, 36,
65). Indeed, it is still controversial whether in excitable tissues
opening of K+ channels leads to
programmed cell death (68) or promotes cellular survival (17, 20, 41).
 |
ACKNOWLEDGEMENTS |
This research was supported by National Heart, Lung, and Blood
Institute Grant HL-0711-22, a Merck Sharp & Dohme International Award
in Clinical Pharmacology, and grants from the American Heart Association, the Miami Heart Research Institute, and the Bruce and Ruth
Rappaport Program in Vascular Biology and Gene Delivery.
 |
FOOTNOTES |
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: A. Terzic, Div. of Cardiovascular
Diseases, Dept. of Medicine, Guggenheim-7F, Mayo Clinic and Foundation,
Rochester, MN 55905.
Received 23 April 1998; accepted in final form 2 July 1998.
 |
REFERENCES |
1.
Aguilar-Bryan, L.,
J. P. Clement,
G. Gonzales,
K. Kunjilwar,
A. Babenko,
and
J. Bryan.
Toward understanding the assembly and structure of KATP channels.
Physiol. Rev.
78:
227-245,
1998[Abstract/Free Full Text].
2.
Alekseev, A. E.,
P. A. Brady,
and
A. Terzic.
Ligand-insensitive state of cardiac ATP-sensitive K+ channels. Basis for channel opening.
J. Gen. Physiol.
111:
381-394,
1998[Abstract/Free Full Text].
3.
Belyaeva, E. A.,
A. Szewczyk,
B. Mikolajek,
M. J. Nalecz,
and
L. Wojtczak.
Demonstration of glibenclamide-sensitive K+ fluxes in rat liver mitochondria.
Biochem. Mol. Biol. Int.
31:
493-500,
1993[Medline].
4.
Brady, P. A.,
A. E. Alekseev,
and
A. Terzic.
Operative condition-dependent response of cardiac ATP-sensitive K+ channels toward sulfonylureas.
Circ. Res.
82:
272-278,
1998[Abstract/Free Full Text].
5.
Brady, P. A.,
S. Zhang,
J. R. Lopez,
A. Jovanovic,
A. E. Aleeksev,
and
A. Terzic.
Dual effect of glyburide, an antagonist of KATP channels, on metabolic inhibition-induced Ca2+ loading in cardiomyocytes.
Eur. J. Pharmacol.
308:
343-349,
1996[Medline].
6.
Brierley, G. P.
The uptake and extrusion of monovalent cations by isolated heart mitochondria.
Mol. Cell. Biochem.
10:
41-62,
1976[Medline].
7.
Chance, B.,
and
G. R. Williamson.
The respiratory chain and phosphorylation.
Adv. Enzyme Regul.
17:
65-134,
1955.
8.
Diwan, J. J.
Mitochondrial transport of K+ and Mg2+.
Biochim. Biophys. Acta
895:
155-165,
1987[Medline].
9.
Dzeja, P. P.,
R. J. Zeleznikar,
and
N. D. Goldberg.
Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle.
J. Biol. Chem.
271:
12847-12851,
1996[Abstract/Free Full Text].
10.
Elvir-Mairena, J. R.,
A. Jovanovic,
L. A. Gomez,
A. E. Alekseev,
and
A. Terzic.
Reversal of the ATP-liganded state of ATP-sensitive K+ channels by adenylate kinase activity.
J. Biol. Chem.
271:
31903-31908,
1996[Abstract/Free Full Text].
11.
Evtodienko, Y. V.,
V. P. Zinchenko,
E. L. Holmuhamedov,
A. V. Gylkhandanyan,
and
A. M. Zhabotinsky.
The stoichiometry of ion fluxes in oscillating mitochondria.
Biochim. Biophys. Acta
589:
157-161,
1980[Medline].
12.
Ferrari, R.
The role of mitochondria in ischemic heart disease.
J. Cardiovasc. Pharmacol.
28:
S1-S10,
1996.
13.
Ferrari, R.,
P. Pedersini,
M. Bongrazio,
G. Gaia,
P. Bernocchi,
F. Di Lisa,
and
O. Visioli.
Mitochondrial energy production and cation control in myocardial ischemia and reperfusion.
Basic Res. Cardiol.
88:
495-512,
1993[Medline].
14.
Findlay, I.
Interactive regulation of the ATP-sensitive potassium channel of cardiac muscle.
J. Cardiovasc. Pharmacol.
24:
S6-S11,
1994.
15.
Garlid, K. D.
Cation transport in mitochondria.
Biochim. Biophys. Acta
1275:
123-126,
1996[Medline].
16.
Garlid, K. D.
Physiology of mitochondria.
In: Cell Physiology. Source Book, edited by N. Sperelakis. New York: Academic, 1998, p. 111-118.
17.
Garlid, K. D.,
P. Paucek,
V. Yarov-Yarovoy,
H. N. Murray,
R. B. Darbenzio,
A. J. D'Alonzo,
N. J. Lodge,
M. A. Smith,
and
G. J. Grover.
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels.
Circ. Res.
81:
1072-1082,
1997[Abstract/Free Full Text].
18.
Garlid, K. D.,
P. Paucek,
V. Yarov-Yarovoy,
X. Sun,
and
P. Schindler.
The mitochondrial KATP channel as a receptor for potassium channel openers.
J. Biol. Chem.
271:
8796-8799,
1996[Abstract/Free Full Text].
19.
Grimmsmann, T.,
and
I. Rustenbeck.
Direct effect of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria.
Br. J. Pharmacol.
123:
781-788,
1998[Medline].
20.
Gross, G. J.
ATP-sensitive potassium channels and myocardial preconditioning.
Basic Res. Cardiol.
90:
85-88,
1995[Medline].
21.
Grover, G. J.
Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion.
Can. J. Physiol. Pharmacol.
75:
309-315,
1997[Medline].
22.
Gunter, T. E.,
K. K. Gunter,
S. Sheu,
and
C. E. Gavin.
Mitochondrial calcium transport: physiological and pathological relevance.
Am. J. Physiol.
267 (Cell Physiol. 36):
C313-C339,
1994[Abstract/Free Full Text].
23.
Halestrap, A. P.
Regulation of mitochondrial metabolism through changes in matrix volume.
Biochem. Soc. Trans.
22:
522-529,
1994[Medline].
24.
Halestrap, A. P.
The regulation of the matrix volume mammalian mitochondria in vitro and its role in control of mitochondrial metabolism.
Biochim. Biophys. Acta
973:
355-382,
1979.
25.
Holmuhamedov, E. L.
Oscillating dissipative structures in mitochondrial suspension.
Eur. J. Biochem.
158:
543-546,
1986[Medline].
26.
Holmuhamedov, E. L.,
E. A. Chukhlova,
V. V. Teplova,
V. P. Zinchenko,
and
Y. V. Evtodienko.
Excitability of inner mitochondrial membrane. Irreversible increase in mitochondrial membrane K+ permeability by divalent cations.
Biol. Membr.
5:
866-872,
1988.
27.
Holmuhamedov, E. L.,
V. V. Teplova,
E. A. Chukhluva,
Y. V. Evtodienko,
and
R. G. Urlich.
Strontium excitability of the inner mitochondrial membrane: regenerative strontium-induced strontium release.
Biochem. Mol. Biol. Int.
36:
39-49,
1995[Medline].
28.
Ichas, F.,
L. S. Jouaville,
S. S. Sidash,
J. P. Mazat,
and
E. L. Holmuhamedov.
Mitochondrial calcium spiking: a transduction mechanism based on calcium-induced permeability transition involved in cell calcium signalling.
FEBS Lett.
348:
211-215,
1994[Medline].
29.
Inoue, I.,
H. Nagase,
K. Kishi,
and
T. Higuti.
ATP-sensitive K+ channel in the mitochondrial inner membrane.
Nature
352:
244-247,
1991[Medline].
30.
Jouaville, L. S.,
F. Ichas,
E. L. Holmuhamedov,
P. Camacho,
and
J. D. Lechleiter.
Synchronization of calcium waves by mitochondrial substrates in Xenopus laevis oocytes.
Nature
377:
438-441,
1995[Medline].
31.
Jovanovic, A.,
A. E. Alekseev,
and
A. Terzic.
Intracellular diadenosine polyphosphates: a novel family of inhibitory ligands of the ATP-sensitive K+ channel.
Biochem. Pharmacol.
54:
219-225,
1997[Medline].
32.
Jovanovic, A.,
S. Jovanovic,
E. Lorenz,
and
A. Terzic.
Recombinant cardiac ATP-sensitive K+ channel subunits confer resistance towards chemical hypoxia-reoxygenation injury.
Circulation
98:
1548-1555,
1998[Abstract/Free Full Text].
33.
Jovanovic, A.,
S. Jovanovic,
D. C. Mays,
J. J. Lipsky,
and
A. Terzic.
Diadenosine 5',5
-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heart.
FEBS Lett.
423:
314-318,
1998[Medline].
34.
Jovanovic, A.,
J. R. Lopez,
A. E. Alekseev,
W. K. Shen,
and
A. Terzic.
Adenosine prevents K+-induced Ca2+ loading: insight into cardioprotection during cardioplegia.
Ann. Thorac. Surg.
65:
586-591,
1998[Abstract/Free Full Text].
35.
Jovanovic, A.,
J. R. Lopez,
and
A. Terzic.
Cytosolic Ca2+ domain-dependent protective action of adenosine in cardiomyocytes.
Eur. J. Pharmacol.
298:
63-69,
1996[Medline].
36.
Jovanovic, A.,
S. Zhang,
A. E. Alekseev,
and
A. Terzic.
Diadenosine polyphosphate-induced inhibition of cardiac KATP channels: operative state-dependent regulation by a nucleoside diphosphate.
Pflügers Arch.
431:
800-802,
1996[Medline].
37.
Jung, D. W.,
E. Chavez,
and
G. P. Brierley.
Energy-dependent exchange of K+ in heart mitochondria.
Arch. Biochem. Biophys.
183:
452-459,
1977[Medline].
38.
Kamo, N.,
M. Muratsugu,
R. Hongoh,
and
Y. Kobatake.
Membrane potential measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state.
J. Membr. Biol.
49:
105-121,
1979[Medline].
39.
Kluck, R. M.,
E. Bossy-Wetzel,
D. R. Green,
and
D. D. Newmayer.
The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis.
Science
275:
1132-1136,
1997[Abstract/Free Full Text].
40.
Krause, S. M.,
and
W. E. Jacobus.
Specific enhancement of the cardiac myofibrillar ATPase by bound creatine kinase.
J. Biol. Chem.
267:
2480-2486,
1992[Abstract/Free Full Text].
41.
Lauritzen, I.,
J. R. De Weille,
and
M. Lazdunski.
The potassium channel opener (
)-cromakalim prevents glutamate-induced cell death in hippocampal neurons.
J. Neurochem.
69:
1570-1579,
1997[Medline].
42.
Lazdunski, M.
ATP-sensitive potassium channels: an overview.
J. Cardiovasc. Pharmacol.
24:
S1-S5,
1994.
43.
Lesnefsky, E. J.,
B. Tandler,
J. Ye,
T. J. Slabe,
J. Turkaly,
and
C. L. Hoppel.
Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H1544-H1554,
1997[Abstract/Free Full Text].
44.
Lopez, J. R.,
R. A. Ghanbari,
and
A. Terzic.
A KATP channel opener protects cardiomyocytes from Ca2+ waves: a laser confocal microscopy study.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H1384-H1389,
1996[Abstract/Free Full Text].
45.
Lopez, J. R.,
A. Jovanovic,
and
A. Terzic.
Spontaneous calcium waves without contraction in cardiac myocytes.
Biochem. Biophys. Res. Commun.
214:
781-787,
1995[Medline].
46.
Lorenz, E.,
A. E. Alekseev,
G. B. Krapivinsky,
A. J. Carrasco,
D. E. Clapham,
and
A. Terzic.
Evidence for direct physical association between a K+ channel (Kir6.2) and an ABC protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K+ channel.
Mol. Cell. Biol.
18:
1652-1659,
1998[Abstract/Free Full Text].
47.
MacLennan, D. H.,
G. Lenaz,
and
L. Szarkovska.
Studies on the mechanism of oxidative phosphorylation. IX. Effect of cytochrome c on energy-linked processes.
J. Biol. Chem.
241:
5251-5259,
1996[Abstract/Free Full Text].
48.
Marton, A.,
R. Mihalik,
A. Bratincsak,
V. Adleff,
I. Petak,
M. Vegh,
P. I. Bauer,
and
P. Krajcsi.
Apoptotic cell death induced by inhibitors of energy conservation.
Eur. J. Biochem.
250:
467-475,
1997[Medline].
49.
Murutsagu, M.,
N. Kamo,
K. Kurihaara,
and
Y. Kobatake.
Selective electrode for dibenzyl dimethyl ammonium cation as indicator of the membrane potential in biological systems.
Biochim. Biophys. Acta
464:
613-619,
1977[Medline].
50.
Noma, A.
ATP-regulated K+ channels in cardiac muscle.
Nature
305:
147-148,
1983[Medline].
51.
Notsu, T.,
I. Tanaka,
M. Takano,
and
A. Noma.
Blockade of the ATP-sensitive K+ channel by 5-hydroxydecanoate in guinea pig ventricular myocytes.
J. Pharmacol. Exp. Ther.
260:
702-708,
1992[Abstract/Free Full Text].
52.
Paucek, P.,
G. D. Mironova,
F. Mahdi,
A. D. Beavis,
G. Woldergiorgis,
and
K. D. Garlid.
Reconstitution and partial purification of the glybenclamide-sensitive, ATP-dependent K+ channel from rat liver and beef heart mitochondria.
J. Biol. Chem.
267:
26062-26069,
1992[Abstract/Free Full Text].
53.
Petronili, V.,
D. Pietrobon,
M. Zoratti,
and
G. F. Azzone.
Free energy coupling between H+-generating and H+-consuming pumps.
Eur. J. Biochem.
155:
423-431,
1986[Medline].
54.
Quast, U.,
and
N. S. Cook.
Moving together: K+ channel openers and ATP-sensitive K+ channels.
Trends Pharmacol. Sci.
10:
431-434,
1989[Medline].
55.
Rauch, U.,
K. Schulze,
B. Witzenbichler,
and
H. P. Schulthesiss.
Alteration of the cytosolic-mitochondrial distribution of high-energy phosphates during global myocardial ischemia contributes to early contractile failure.
Circ. Res.
75:
760-769,
1994[Abstract/Free Full Text].
56.
Reed, J. C.
Cytochrome c: can't live with it
can't live without it.
Cell
91:
559-562,
1997[Medline].
57.
Romashko, D. N.,
E. Marban,
and
B. O'Rourke.
Subcellular metabolic transients and mitochondrial redox waves in heart cells.
Proc. Natl. Acad. Sci. USA
95:
1618-1623,
1998[Abstract/Free Full Text].
58.
Schnaitman, C.,
and
J. W. Greenawalt.
Enzymatic properties of the inner and outer membranes of rat liver mitochondria.
J. Cell Biol.
38:
158-175,
1968[Abstract/Free Full Text].
59.
Seino, S.,
N. Inagaki,
N. Namba,
and
T. Gonoi.
Molecular biology of the
-cell ATP-sensitive K+ channel.
Diabetes Rev.
4:
177-190,
1996.
60.
Suzuki, M.,
K. Kotake,
K. Fujikura,
N. Inagaki,
T. Suzuki,
T. Gonoi,
S. Seino,
and
K. Takata.
Kir6.1. A possible subunit of ATP-sensitive K+ channels in mitochondria.
Biochem. Biophys. Res. Commun.
241:
693-697,
1997[Medline].
61.
Szewczyk, A.
Intracellular targets for antidiabetic sulfonylureas and potassium channel openers.
Biochem. Pharmacol.
54:
961-965,
1997[Medline].
62.
Szewczyk, A.,
A. Czyz,
G. Wojcik,
L. Wojczak,
and
M. Nalecz.
ATP-regulated K+ channel in mitochondria: pharmacology and function.
J. Bioenerg. Biomembr.
28:
147-152,
1996[Medline].
63.
Szewczyk, A.,
G. Wojcik,
N. A. Lobanov,
and
M. J. Nalecz.
The mitochondrial sulfonylurea receptor: identification and characterization.
Biochem. Biophys. Res. Commun.
230:
611-615,
1997[Medline].
64.
Szewczyk, A.,
G. Wojcik,
and
M. Nalecz.
Potassium channel opener, RP 66471, induces membrane depolarization of rat liver mitochondria.
Biochem. Biophys. Res. Commun.
207:
126-132,
1995[Medline].
65.
Terzic, A.,
I. Findlay,
Y. Hosoya,
and
Y. Kurachi.
Dualistic behavior of ATP-dependent K+ channel towards intracellular nucleoside diphosphates.
Neuron
12:
1049-1058,
1994[Medline].
66.
Terzic, A.,
A. Jahangir,
and
Y. Kurachi.
Cardiac ATP-sensitive K+ channel regulation by intracellular nucleotides and K+channel opening drugs.
Am. J. Physiol.
269 (Cell Physiol. 38):
C525-C545,
1995[Abstract/Free Full Text].
67.
Terzic, A.,
R. T. Tung,
and
Y. Kurachi.
Nucleotide regulation of ATP sensitive potassium channels.
Cardiovasc. Res.
28:
746-753,
1996.
68.
Yu, S. P.,
C. H. Yeh,
S. L. Sensi,
B. J. Gwag,
L. M. T. Canzoniero,
Z. S. Fahrangrazi,
H. S. Ying,
M. Tian,
L. l. Dugan,
and
D. W. Choi.
Mediation of neuronal apoptosis by enhancement of outward potassium current.
Science
278:
114-117,
1997[Abstract/Free Full Text].
Am J Physiol Heart Circ Physiol 275(5):H1567-H1576
0002-9513/98 $5.00
Copyright © 1998 the American Physiological Society